Search results for: 'drug eluting b'

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping drug discovery, diagnostics, and therapeutic delivery across oncology, infectious diseases, rare and metabolic disorders, neuromuscular and neurodegenerative conditions, diabetes, ophthalmol...

Globally, diagnosis of metabolic diseases such as type 2 diabetes and obesity have increased. Since the COVID-19 pandemic, the global prevalence of obesity has worsened. Obesity is considered a main precursor of diabetes and contributes an estimated 80% to 85% toward the risk of type 2 diabetes. As a result, the financial burden associated with hea...

Food & Beverage (F&B) manufacturing has embraced IIoT, AI, MES, ERP, and more such tools to move up production and quality. Advancements in real-time data processing and predictive analytics further help introduce new ways of utilizing data to generate insights for effective decision-making. Successful F&B companies are constantly innovating and up...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) comprise innovation insights across antibody and cellular therapies. The study also encompasses recent innovations in liquid biopsy tests, drug delivery and drug discovery platforms.The Life Science, Health & Wellness TOE will feature disruptive technology advan...

This research service covers the U.S. injectable drug pipeline in 2009. Included are technology trends, Phase III pipeline analysis, selected Phase II and I pipeline analysis. The market is segmented by injectable drug delivery route: subcutaneous injectables, intravenous injectables, intramuscular injectables, and others. Major market challenges,...

The era of robotics is becoming a disruptive force in the food and beverage (F&B) industry, most notably in production, services, and delivery. By leveraging advanced AI, sensing technologies, and adaptive automation, robotic technologies are delivering groundbreaking advancements in operational precision, performance, and reliability. This transfo...

This research service explores the market for drug delivery used for the treatment of ocular diseases in the Unites States of America. It analyzes the various challenges faced by pharmaceutical, biotech, and drug delivery companies, and the competitive advantages and disadvantages of their products in the market.

Several industries are witnessing a digital transformation due to the rise in technologies and Industry 4.0. The food and beverage (F&B) industry is seeing a new range of opportunities with improved connectivity, better food safety, and consumer interaction. F&B considers food safety to be prime due to the burden of food contamination and foodborn...

17 Mar 2015  |  Global  |  Market Research

Analysis of the Global Diabetes Drug Delivery Market

Future Options for End Users

Infographics

×

The global diabetes drug delivery market is mainly divided into injectable drug delivery and oral drug delivery systems. The trend will continue in 2015, as four major products: Afrezza (inhalable drug delivery product of MannKind distributed by Sanofi), Tanzeum (injectable pen), Xigduo XR (oral), and Xultophy (injectable pen) enter the US and Euro...